Skip to Content
Merck
CN
HomeBreaking bottlenecks: chromatography for intensified processing

Breaking bottlenecks: chromatography for intensified processing

How does process intensification impact chromatography?

Chromatography remains central to downstream bioprocessing, particularly for monoclonal antibody (mAb) capture and polishing. Established packed-bed resin platforms provide selectivity, robustness, scalability, and regulatory familiarity for clinical and commercial manufacturing.

But process demands are changing. Higher upstream titers, more diverse product pipelines and the pressure to manufacture more products in shorter timelines are pushing facilities to improve productivity, reduce footprint and increase flexibility while maintaining or improving product quality.

These demands are exposing the limits of conventional downstream strategies. The question is no longer achieving the required purity within standard mAb processes; it is achieving that purity faster, with better media utilization, lower resource demand, and a process architecture suited to modern manufacturing. 

This is why chromatography is a key focus area for process intensification.

Key takeaways:

  • Chromatography bottlenecks are shifting from purity alone to productivity and process fit. Modern downstream processes must handle higher upstream titers, greater product mass, shorter timelines, and smaller facility footprints while still meeting quality requirements.
  • Productivity is the practical measure of chromatography intensification. Capacity matters, but the more useful question is how many grams of product can be processed per liter of resin or membrane per hour, factoring in residence time, cycle time, buffer use, cleaning, and media lifetime.
  • The right technology depends on the bottleneck. Resins remain important for robust selectivity, lifecycle performance, and established scale-up, while membranes and other convective formats can help when mass transfer, residence time, and processing speed are limiting.
  • Process intensification requires looking beyond the chromatography column. Buffer demand, feed conditioning, connected operations, automation, analytics, facility fit, and implementation risk all influence whether an intensified chromatography strategy delivers practical process and economic benefits.

Why is chromatography a bottleneck?

Chromatography can constrain downstream performance when legacy technologies with lower binding capacity or longer residence times cannot keep pace with higher upstream titers. In other cases, the bottleneck is product quality, such as aggregate removal, host cell protein clearance, charge-variant resolution, or separation of closely related variants.

Buffer use, column size, media lifetime, cycle time, cleaning requirements, and facility fit can also limit performance. A chromatography step may work well in isolation but still create pressures elsewhere in the process.

Defining the bottleneck before selecting the technology is critical. Capacity, mass transfer, selectivity, buffer use, footprint, cycle time, and implementation challenges may each point to a different solution from higher-capacity resins to membranes, feed conditioning, multicolumn operation, or connected process architectures.

How does productivity affect process economics?

As upstream titers increase, downstream chromatography must process more product mass without necessarily adding facility capacity or equipment.

Higher dynamic binding capacity can help, but capacity alone does not determine productivity. Residence time, loading conditions, wash and elution volumes, lifetime stability, pressure-flow behavior and cycle count all contribute to overall performance.

For intensified chromatography, the key question is often:

How many grams of product can be processed per liter of resin or membrane per hour?

The goal is to maximize the amount of product that can be processed over time within the available manufacturing footprint, not simply to maximize binding. This requires aligning purification with upstream output, including harvest volume, titer, product mass, impurity profile, and process variability.

For process development and MSAT teams, intensification of chromatography steps becomes practical when it improves productivity. Productivity links technical performance to manufacturing outcomes such as shorter processing time, smaller media volumes, reduced buffer use, lower facility footprint, and improved utilization of existing assets.

Published studies show that intensification can improve chromatography economics through higher productivity and better media utilization, not simply by adding more resin.1

How does capacity impact speed?

Chromatography media must balance binding capacity, selectivity, pressure-flow performance, chemical stability, and mass-transfer behavior. Improving one parameter can sometimes limit another, especially when drug manufacturers seek shorter residence time and higher throughput.

Conventional porous particles rely primarily on diffusion, which can limit how quickly larger or more complex molecules reach binding sites. Convective technologies, including membrane chromatography, can reduce this limitation by enabling faster access to binding sites and shorter residence times. Scalable, single-use membrane devices can also avoid column packing, cleaning, and re-validation between batches, reducing time and operational burden.

The practical decision is not resin versus membrane. It is which format best solves the defined bottleneck: mass transfer, residence time, selectivity, lifecycle performance, aggregate clearance, or platform fit.

Why resource consumption and footprint matter

Chromatography performance should be evaluated beyond the column or membrane device and consider both loading and non-loading components of each cycle. Equilibration, washing, elution, regeneration, cleaning, and buffer exchange require significant buffer and water volumes, affecting preparation capacity, storage space, labor, facility layout, single-use assemblies, and waste handling. These operational requirements shape the sustainability profile for this step.

Buffer demand is often underestimated. Higher upstream titers increase product mass and can increase pressure on buffer preparation and delivery systems.2 A step that improves column productivity but creates a buffer bottleneck may not improve the overall process.

Intensified approaches can reduce resource demand and highlight how process efficiency cannot be measured by throughput alone.3,4 Evaluation should consider buffer volume, cycle count, facility fit, consumable use, cleaning, hold steps, analytics, labor, and implementation risk.

From optimization to intensification

Intensification does not always require replacing a chromatography medium. In some cases, feed concentration or connecting operations can improve performance.

For example, single-pass tangential flow filtration before chromatography can reduce load volume, increase mass loading, and improve buffer efficiency. In one polishing case study, pre-concentration before anion exchange polishing enabled a four-fold increase in mass loading while maintaining host cell protein clearance.5 In a capture case study, inline concentration before multicolumn chromatography reduced resin volume requirements and improved resin productivity while maintaining the same product mass flow.6

Connected polishing trains can also reduce intermediate holds and buffer demand while supporting cumulative impurity clearance.

This shifts intensification from a media-selection question to a process-design question involving separation format, operating mode, feed conditioning, automation, analytics, and facility configuration.

Traditional chromatography development often focuses on optimizing individual parameters, but this has limitations if the overall processing architecture remains unchanged. Intensification takes a broader view and may involve:

  • Increasing usable capacity and media utilization
  • Improving productivity in grams of product per liter of resin or membrane per hour
  • Reducing residence time while maintaining performance
  • Using multimodal or more selective chemistries for difficult impurity profiles
  • Introducing membrane chromatography or other convective formats
  • Implementing rapid-cycle or multicolumn operation
  • Connecting, or eliminating purification steps
  • Conditioning or concentrating feed before chromatography
  • Selecting technologies based on the primary bottleneck
  • Tailoring purification strategies to the molecule

Resin-based columns remain the dominant technology in bioprocess chromatography, while membranes, monoliths, and fiber-based formats are gaining ground in select applications.7 The opportunity ahead is to identify where each technology provides the greatest advantage.

Rethinking the role of chromatography

The future of chromatography is not a simple choice between established resin platforms and emerging membrane technologies but a more deliberate match between technology, process architecture and the bottleneck being addressed.

Resins remain essential where binding capacity, selectivity, scale-up, lifecycle performance, and regulatory familiarity are required. Membranes and other convective formats can help where mass transfer, residence time, flexibility and process speed are limited. Feed-conditioning and connected operations can further reduce load volume, buffer demand and intermediate holds.

This shift — from capacity to productivity, and from unit operation optimization to process intensification — is shaping next-generation downstream chromatography.

For process development and MSAT teams, breaking chromatography bottlenecks starts with understanding the process constraints and thinking broadly about solutions to address them.

Loading
1.
2020. Application Note. Multi-Column Capture Prototype Tests for Monoclonal Antibody Capture During Project. nextBioPharmDSP . MilllliporeSigma Lit. No. AN7549EN
2.
2020. eBook: Convergent Bioprocessing: Standing At The Intersection Of Advanced Process And Digital Technologies. [Internet]. Bioprocess Online: MilliporeSigma. Available from: https://www.bioprocessonline.com/doc/convergent-bioprocessing-standing-at-the-intersection-of-advanced-process-and-digital-technologies-0001
3.
Isaksson M, Andersson N, Nilsson B. 2025. Improving the sustainability of biopharmaceutical downstream processing through buffer recycling. Journal of Chromatography A. 1740465545. https://doi.org/10.1016/j.chroma.2024.465545
4.
Schmitz F, Minceva M, Kampmann M. 2024. Comparison of batch and continuous multi-column capture of monoclonal antibodies with convective diffusive membrane adsorbers. Journal of Chromatography A. 1732465201. https://doi.org/10.1016/j.chroma.2024.465201
5.
Elich T, Goodrich E, Lutz H, Mehta U. 2019. Investigating the combination of single‐pass tangential flow filtration and anion exchange chromatography for intensified mAb polishing. Biotechnology Progress. 35(5): https://doi.org/10.1002/btpr.2862
6.
Rahane SB, Gupta A, Szymanski P, Kinzlmaier D, McGee P, Goodrich E. 2024. Concentration of clarified pool by single‐pass tangential flow filtration to improve productivity of protein A capture step: Impact of clarification strategies. Biotech & Bioengineering. 121(3):1090-1101. https://doi.org/10.1002/bit.28634
7.
2026. eBook: Chromatography — Advanced Materials, Predictive Technologies, and Continuous Operations. [Internet]. BioProcess International: Yunha Hwang, Myungkyung Mia Hyun, Cheolgi Lee, Christine Quern, Gregory Saunders. Available from: https://www.bioprocessintl.com/chromatography/ebook-chromatography-advanced-materials-predictive-technologies-and-continuous-operations